For the third quarter of 2016, Boston Scientific’s revenue increased 11 percent to $2.11 billion compared with the same period last year. The company announced in an Oct. 26 news release that it beat its guidance, which was $2.04 billion to $2.09 billion.

If the Centers for Medicare & Medicaid Services (CMS) weighted 30-day readmissions and mortality equally, financial penalties in 2014 for U.S. hospitals would have substantially changed, according to an analysis of publicly available hospital data.

A recent analysis of that study suggests that intensive blood pressure management may be cost-effective for adults who are at least 50 years old, have hypertension but do not have diabetes and are at high risk for cardiovascular disease.

A cardiologist in Florida has filed a lawsuit against a psychiatrist who performed electroconvulsive therapy while treating him for depression, Courtroom View Network reports.

For the third quarter of 2016, Abbott’s sales increased 2.9 percent to $5.3 billion compared with the same time period last year. The company also posted a $0.24 loss in diluted earnings per share, which it said was primarily due to a $0.66 per share adjustment related to its investment in Mylan.

Shortly after a research firm posted videos Oct. 19 that allegedly showed cybersecurity vulnerabilities with St. Jude Medical’s cardiac devices, the company issued a statement criticizing the release of the videos.

Patients with atrial fibrillation who received cryoballoon catheter ablation had lower healthcare costs and fewer rehospitalizations and repeat ablations compared with those who received radiofrequency ablation, according to a health economic analysis.

Medical device makers are supporting Minnesota Congressman Erik Paulsen in his bid for re-election, STAT reports.